MA49019A - Nouveaux modulateurs du récepteur sigma 2 et leur procédé d'utilisation - Google Patents
Nouveaux modulateurs du récepteur sigma 2 et leur procédé d'utilisationInfo
- Publication number
- MA49019A MA49019A MA049019A MA49019A MA49019A MA 49019 A MA49019 A MA 49019A MA 049019 A MA049019 A MA 049019A MA 49019 A MA49019 A MA 49019A MA 49019 A MA49019 A MA 49019A
- Authority
- MA
- Morocco
- Prior art keywords
- new sigma
- receiver modulators
- modulators
- receiver
- sigma
- Prior art date
Links
- 102100037651 AP-2 complex subunit sigma Human genes 0.000 title 1
- 101000806914 Homo sapiens AP-2 complex subunit sigma Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762474277P | 2017-03-21 | 2017-03-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA49019A true MA49019A (fr) | 2020-02-05 |
Family
ID=63585700
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA049019A MA49019A (fr) | 2017-03-21 | 2018-03-15 | Nouveaux modulateurs du récepteur sigma 2 et leur procédé d'utilisation |
Country Status (5)
| Country | Link |
|---|---|
| US (3) | US10961249B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3600290B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7365237B2 (cg-RX-API-DMAC7.html) |
| MA (1) | MA49019A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018175188A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9802924B2 (en) | 2013-03-11 | 2017-10-31 | Temple University Of The Commonwealth System Of Higher Education | 5-hydroxytryptamine receptor 7 activity modulators and their method of use |
| EP3200589B1 (en) | 2014-09-10 | 2026-03-11 | Temple University Of The Commonwealth System Of Higher Education | Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use |
| US10858368B2 (en) | 2016-11-15 | 2020-12-08 | Temple University—Of the Commonwealth System of Higher Education | Modulators of the 5-hydroxytryptamine receptor 7 and their method of use |
| JP7365237B2 (ja) * | 2017-03-21 | 2023-10-19 | テンプル・ユニバーシティ-オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション | シグマ-2受容体の新規調節物質およびその使用方法 |
| EP3600289A4 (en) | 2017-03-21 | 2020-08-05 | Temple University - Of The Commonwealth System of Higher Education | 5-HYDROXYTRYPTAMINE RECEPTOR 7 MODULATORS AND THE USE OF THESE AS THERAPEUTIC AGENTS |
| WO2019217890A1 (en) * | 2018-05-11 | 2019-11-14 | Temple University-Of The Commonwealth System Of Higher Education | Novel functionalized lactams as modulators of the 5-hydroxytryptamine receptor 7 and their method of use |
| GB201809295D0 (en) | 2018-06-06 | 2018-07-25 | Institute Of Cancer Res Royal Cancer Hospital | Lox inhibitors |
| CN112010859B (zh) * | 2019-05-30 | 2022-07-19 | 中国科学院上海药物研究所 | 一种并环化合物、其制备方法和用途 |
| AU2023323878A1 (en) * | 2022-08-11 | 2025-01-30 | Remynd N.V. | (aza)spiroheptane derivatives for the treatment of neurodegenerative disorders |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2005219438B2 (en) * | 2004-03-03 | 2011-02-17 | Chemocentryx, Inc. | Bicyclic and bridged nitrogen heterocycles |
| GB0419192D0 (en) * | 2004-08-27 | 2004-09-29 | Merck Sharp & Dohme | Therapeutic agents |
| JP2010509402A (ja) * | 2006-11-13 | 2010-03-25 | キング・ファーマシューティカルズ・リサーチ・アンド・デベロプメント・インコーポレイティッド | A1アデノシン受容体のアロステリック調節剤 |
| US8148408B2 (en) * | 2008-05-09 | 2012-04-03 | Abbott Laboratories | Selective substituted pyridine ligands for neuronal nicotinic receptors |
| US8697888B2 (en) * | 2012-01-06 | 2014-04-15 | Vanderbilt University | Substituted (1-(methylsulfonyl)azetidin-3-yl)(heterocycloalkyl)methanone analogs as antagonists of muscarinic acetylcholine M1 receptors |
| WO2014085413A1 (en) | 2012-11-28 | 2014-06-05 | Temple University - Of The Commonwealth System Of Higher Education | Disubstituted oxazolidin-2-ones 5-hydroxytryptamine receptor 2b activity modulators |
| EP2928474B1 (en) | 2012-12-07 | 2018-11-14 | ChemoCentryx, Inc. | Diazole lactams |
| US9802924B2 (en) | 2013-03-11 | 2017-10-31 | Temple University Of The Commonwealth System Of Higher Education | 5-hydroxytryptamine receptor 7 activity modulators and their method of use |
| US9809545B2 (en) * | 2013-03-27 | 2017-11-07 | Merck Sharp & Dohme Corp. | Factor XIa inhibitors |
| KR20160098506A (ko) * | 2013-12-20 | 2016-08-18 | 라보라토리오스 델 드라. 에스테브.에스.에이. | 통증에 대한 다양한 활성을 갖는 피페라진 유도체 |
| EP3200589B1 (en) | 2014-09-10 | 2026-03-11 | Temple University Of The Commonwealth System Of Higher Education | Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use |
| CR20170118A (es) * | 2014-10-08 | 2017-07-10 | Hoffmann La Roche | Derivados espirodiamina como inhibidores de la aldosterona sintasa |
| TWI698436B (zh) * | 2014-12-30 | 2020-07-11 | 美商佛瑪治療公司 | 作為泛素特異性蛋白酶7抑制劑之吡咯并及吡唑并嘧啶 |
| US20180221365A1 (en) * | 2015-05-12 | 2018-08-09 | Temple University-Of The Commonwealth System Of Higher Education | Novel sigma-2 receptor binders and their method of use |
| US10858368B2 (en) * | 2016-11-15 | 2020-12-08 | Temple University—Of the Commonwealth System of Higher Education | Modulators of the 5-hydroxytryptamine receptor 7 and their method of use |
| EP3600289A4 (en) | 2017-03-21 | 2020-08-05 | Temple University - Of The Commonwealth System of Higher Education | 5-HYDROXYTRYPTAMINE RECEPTOR 7 MODULATORS AND THE USE OF THESE AS THERAPEUTIC AGENTS |
| JP7365237B2 (ja) | 2017-03-21 | 2023-10-19 | テンプル・ユニバーシティ-オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション | シグマ-2受容体の新規調節物質およびその使用方法 |
| WO2019217890A1 (en) | 2018-05-11 | 2019-11-14 | Temple University-Of The Commonwealth System Of Higher Education | Novel functionalized lactams as modulators of the 5-hydroxytryptamine receptor 7 and their method of use |
| CN115003675A (zh) | 2019-11-13 | 2022-09-02 | 英联邦高等教育系统坦普尔大学 | 作为5-羟色胺受体7调节剂的新型官能化内酰胺及其使用方法 |
| MX2022005819A (es) | 2019-11-13 | 2022-08-16 | Univ Temple | Nuevas lactonas funcionalizadas como moduladores del receptor 7 de 5-hidroxitriptamina y su método de uso. |
-
2018
- 2018-03-15 JP JP2019551998A patent/JP7365237B2/ja active Active
- 2018-03-15 WO PCT/US2018/022574 patent/WO2018175188A1/en not_active Ceased
- 2018-03-15 MA MA049019A patent/MA49019A/fr unknown
- 2018-03-15 EP EP18772377.0A patent/EP3600290B1/en active Active
- 2018-03-15 US US16/496,073 patent/US10961249B2/en active Active
-
2021
- 2021-01-21 US US17/154,761 patent/US11820774B2/en active Active
-
2023
- 2023-10-06 JP JP2023174368A patent/JP7781122B2/ja active Active
- 2023-10-11 US US18/484,858 patent/US12577251B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20210363145A1 (en) | 2021-11-25 |
| JP7365237B2 (ja) | 2023-10-19 |
| JP7781122B2 (ja) | 2025-12-05 |
| JP2020511506A (ja) | 2020-04-16 |
| US20200039985A1 (en) | 2020-02-06 |
| US20240300954A1 (en) | 2024-09-12 |
| EP3600290C0 (en) | 2025-06-04 |
| EP3600290A1 (en) | 2020-02-05 |
| US10961249B2 (en) | 2021-03-30 |
| WO2018175188A1 (en) | 2018-09-27 |
| EP3600290A4 (en) | 2020-08-12 |
| JP2023168623A (ja) | 2023-11-24 |
| US12577251B2 (en) | 2026-03-17 |
| US11820774B2 (en) | 2023-11-21 |
| EP3600290B1 (en) | 2025-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3344806A4 (en) | GLYCANARRAYS AND METHOD OF USE | |
| EP3310305A4 (en) | BRANCHED AORTIC TRANSPLANT AND METHOD OF USE THEREOF | |
| EP3603543A4 (en) | TOURNIQUET AND HEMOSTATIC PROCEDURE | |
| EP3541790A4 (en) | NEW MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR 7 AND THEIR METHOD FOR USE THEREOF | |
| EP3368404A4 (en) | SEPARATE TOWER JOINT ARRANGEMENT AND METHOD FOR USE THEREOF | |
| EP3303634A4 (en) | CAS9 VARIANTS AND METHOD FOR USE THEREOF | |
| MA45996A (fr) | Variants d'endonucléase de homing du récepteur alpha de l'il-10, compositions et méthodes d'utilisation associées | |
| EP3385835A4 (en) | METHOD AND DEVICE FOR CONFIGURING A ACCELERATOR | |
| EP3119761C0 (en) | ANTI-AMYLOID AGENTS AND METHODS OF USE THEREOF | |
| EP3371930A4 (en) | METHOD AND DEVICE FOR SECURE AGGREGATED EVENT MESSAGE | |
| EP3368663A4 (en) | VIRUS-FREE CELL LINES AND METHOD FOR THE MANUFACTURE THEREOF | |
| EP3632933A4 (en) | Novel anti-cd40 antibodies and use thereof | |
| EP3816282A4 (en) | LUCIFERIN BIOSYNTHETIC ENZYMES AND THEIR USE | |
| EP3638037A4 (en) | INSECTICIDAL PROTEINS FROM PLANTS AND METHOD OF USING THEM | |
| EP3073705A4 (en) | CHANNEL MANUFACTURING METHOD AND DEVICE | |
| EP3604367A4 (en) | BLOCK CO-POLYMER AND METHOD FOR MANUFACTURING A BLOCK CO-POLYMER | |
| EP3101933A4 (en) | PHYSICAL CELL IDENTIFIER ASSIGNMENT METHOD AND DEVICE | |
| EP3852015A4 (en) | SURGICAL ACCELERATOR AND COMPRESSION PROCEDURES | |
| EP3411046A4 (en) | RAPAGLUTINES, NOVEL GLUT INHIBITORS AND USES THEREOF | |
| EP3478052A4 (en) | INSECTICIDE PROTEINS FROM PLANTS AND METHODS FOR THEIR USE | |
| EP3334522A4 (en) | ADSORPTION AGENTS AND METHOD FOR THE PRODUCTION AND USE OF ADSORPTION AGENTS | |
| MA50440A (fr) | Imidazopyridinamides substituées et leur utilisation | |
| EP3684437A4 (en) | METHOD AND DEVICE FOR FILTERING | |
| EP3528631A4 (en) | PLANT INSECTICIDE PROTEINS AND METHOD FOR USE THEREOF | |
| MA44087A (fr) | Immunothérapie basée sur la listéria et ses méthodes d'utilisation |